Cardiometabolic syndrome and associated factors among Ethiopian public servants, Addis Ababa, Ethiopia.
Adult
Blood Glucose
Body Mass Index
Cardiovascular Diseases
/ complications
Diabetes Mellitus
/ physiopathology
Ethiopia
/ epidemiology
Exercise
/ trends
Female
Humans
Hypertension
/ physiopathology
Life Style
/ ethnology
Male
Metabolic Syndrome
/ epidemiology
Middle Aged
Obesity
/ complications
Obesity, Abdominal
/ complications
Occupational Stress
/ physiopathology
Prevalence
Public Health
Public Health Administration
Risk Factors
Social Welfare
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 10 2021
19 10 2021
Historique:
received:
29
12
2020
accepted:
01
10
2021
entrez:
20
10
2021
pubmed:
21
10
2021
medline:
9
2
2022
Statut:
epublish
Résumé
Non-communicable diseases (NCDs) are increasingly becoming the global cause of premature death encompassing cardiovascular diseases (CVDs), cancer, respiratory diseases and diabetes mellitus. However, cardiometabolic risk factors in the general population, especially among the high-risk groups have rarely been assessed in Ethiopia. The study aimed to assess the prevalence of metabolic syndrome, its components and associated factors among staff in the Ethiopian Public Health Institute (EPHI). An institutional-based cross-section study was conducted from March to June 2018 among EPHI staff members. A total of 450 study participants were involved in the study, and the World Health Organization NCD STEPS survey instrument version 3.1 was used for the assessment. The biochemical parameters were analyzed by using COBAS 6000 analyzer. Statistical package for the social science (SPSS) version 20 was used for data analysis. Both bivariate and multivariate logistic regression analyses were used to identify associated risk factors. p value < 0.05 was considered for statistical significance. The overall prevalence of metabolic syndrome was 27.6% and 16.7% according to IDF and NCEP criteria respectively, with males having greater prevalence than females (35.8% vs 19.4%). Central obesity, low high-density lipoprotein (HDL) and hypertension had a prevalence of 80.2%, 41.3%, and 23.6%, respectively. In multivariate analysis increasing age and having a higher body mass index (25-29.9) were significantly associated with metabolic syndromes. The magnitude of metabolic syndrome was relatively high among public employees. Preventive intervention measures should be designed on the modification of lifestyle, nutrition and physical activities, and early screening for early identification of cardiometabolic risks factors should be practised to reduce the risk of developing cardiovascular diseases.
Identifiants
pubmed: 34667235
doi: 10.1038/s41598-021-99913-6
pii: 10.1038/s41598-021-99913-6
pmc: PMC8526710
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20635Informations de copyright
© 2021. The Author(s).
Références
BMC Public Health. 2013 Dec 18;13:1198
pubmed: 24350922
Diabetes Res Clin Pract. 2007 Sep;77(3):471-8
pubmed: 17350710
Cardiovasc J Afr. 2017 May/Jun 23;28(3):147-153
pubmed: 27701489
BMC Med. 2017 Sep 28;15(1):173
pubmed: 28954635
Diabetes Metab. 2012 Nov;38(5):428-35
pubmed: 22721723
Arch Med Sci. 2013 Apr 20;9(2):243-53
pubmed: 23671434
Cell Mol Life Sci. 2012 Sep;69(18):2999-3013
pubmed: 22446749
Obes Facts. 2009;2(2):97-103
pubmed: 20054212
BMC Res Notes. 2017 Nov 28;10(1):629
pubmed: 29183367
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14
pubmed: 19896746
PLoS One. 2018 May 9;13(5):e0194819
pubmed: 29742131
Diabetol Metab Syndr. 2015 Feb 11;7:6
pubmed: 25717347
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S81-S85
pubmed: 28024832
Nutr Res. 2009 Mar;29(3):180-9
pubmed: 19358932
Diabetol Metab Syndr. 2018 Feb 21;10:10
pubmed: 29483948
Metab Syndr Relat Disord. 2018 Oct;16(8):395-405
pubmed: 30063173
Pak J Med Sci. 2015 Nov-Dec;31(6):1377-82
pubmed: 26870100
Diabetes Care. 2012 Apr;35(4):887-93
pubmed: 22374643
Sci Rep. 2018 Jun 18;8(1):9298
pubmed: 29915239
Int J Environ Res Public Health. 2017 Feb 27;14(3):
pubmed: 28264459
J Cardiometab Syndr. 2006 Winter;1(1):25-8
pubmed: 17675903
PLoS One. 2014 Mar 10;9(3):e91578
pubmed: 24614618
J Urban Health. 2013 Dec;90(6):1016-25
pubmed: 23440487
Diabet Med. 2010 May;27(5):593-7
pubmed: 20536958
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Asian Pac J Cancer Prev. 2014;15(18):7897-907
pubmed: 25292084
Nat Rev Dis Primers. 2017 Jun 15;3:17034
pubmed: 28617414
Vasc Health Risk Manag. 2016 Dec 14;12:497-503
pubmed: 28008265
Diabetes Metab Syndr. 2014 Apr-Jun;8(2):102-7
pubmed: 24907175
Br J Psychiatry. 2012 Oct;201(4):306-12
pubmed: 22878134
Int J Hypertens. 2011;2011:193719
pubmed: 21747973
Diabetes Obes Metab. 2001 Feb;3(1):17-23
pubmed: 11213595
BMC Res Notes. 2017 Jul 6;10(1):251
pubmed: 28683811
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S359-S364
pubmed: 28284909
Diabetes Care. 2010 Nov;33(11):2457-61
pubmed: 20699434
Alcohol. 2020 Mar;83:83-88
pubmed: 31525410
Semin Nephrol. 2013 Jan;33(1):2-13
pubmed: 23374889
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
J Atheroscler Thromb. 2005;12(6):295-300
pubmed: 16394610
PLoS One. 2014 Aug 20;9(8):e105581
pubmed: 25141255
Lancet. 2011 Feb 12;377(9765):578-86
pubmed: 21295847
PLoS One. 2016 Nov 4;11(11):e0165036
pubmed: 27814369
Public Health. 2015 May;129(5):413-23
pubmed: 25736900
J Clin Hypertens (Greenwich). 2012 Nov;14(11):792-8
pubmed: 23126352
Nat Rev Endocrinol. 2014 May;10(5):293-302
pubmed: 24663222
Schizophr Res. 2016 Feb;170(2-3):290-300
pubmed: 26794596
Cardiovasc J Afr. 2010 Jan-Feb;21(1):26-31
pubmed: 20224842